🇺🇸 FDA
Pipeline program

Cisplatin Accord Healthcare 1 mg/ml concentraat voor oplossing voor infusie

Approved small_molecule active

Quick answer

Cisplatin Accord Healthcare 1 mg/ml concentraat voor oplossing voor infusie for Locally advanced head and neck squamous cell carcinoma is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Locally advanced head and neck squamous cell carcinoma
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials